Xuebijing and somatostatin against acute pancreatitis: A systematic review and network pharmacology.

ABSTRACT:

Background

Acute pancreatitis (AP) is a common pancreatic disease. Xuebijing injection (XBJ) combined with somatostatin in the treatment of AP is frequently used in clinical practice. There is, however, a lack of high-quality evidence-based evidence and network pharmacology to regard the therapeutic efficacy and pharmacological mechanisms.

Purpose

The purpose of this study is to investigate the potential therapeutic targets and pharmacological mechanism of XBJ in AP using integrating evidence-based medicine and network pharmacology.

Methods

PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure, Weipu, and Wanfang databases were searched. Randomized controlled trials of XBJ combined with somatostatin (experimental group) versus somatostatin alone (c

SUBMITTER: Cao JP 

PROVIDER: S-EPMC11651499 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature